North Carolina experts discussed CLL, breast cancer, and myeloma treatments and how to expand access to complex cancer care beyond academic centers.
|Articles|May 4, 2012
Paul Dobesh, PharmD, Points Out the Benefits of Combining Anticoagulant and Antiplatelet Treatments
Dr. Dobesh addresses the challenges of achieving efficacy without having the patient bleed when combining anticoagulant and antiplatelet treatments.
Advertisement
Paul Dobesh, PharmD, addresses the challenges in trying to simplify medication regiments in cardiovascular disease to improve clinical outcomes and increase adherence.
Advertisement
Related to this article
The IRA's Medicare out-of-pocket cap is easing costs for patients with cancer, but community oncology leaders warn price cuts are straining practices.
A follicular lymphoma survivor shares axi-cel CAR T-cell therapy highs, experiences with severe CRS and neurotoxicity, and why access to care and clinical trials improve quality of life.
Biomarker testing, referrals, screening, treatment access, and clinical trial barriers were examined during this recent IVBM.
Oncologists say advances in testing and treatment are outpacing staffing, pay, and access.
Home NB-UVB phototherapy matches office results, boosts psoriasis treatment adherence, and may improve access, but long-term safety, equity, and oversight lag.
Upper-extremity synovial sarcoma required more staged surgery, while lower-extremity disease carried more complications and metastases.
In the US alone, 1.1 million individuals are living with the progressive neurodegenerative movement disorder, and 90,000 are diagnosed each year.
Advertisement
Advertisement